You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Compressive Spectral Video in the LWIR

    SBC: Physical Sciences Inc.            Topic: A13AT015

    Physical Sciences Inc. and Colorado State University will develop an innovative sensor that enables low-cost infrared hyperspectral imaging though the use of novel sampling algorithms which provide real-world chemical plume detection capability with compressed data and a hardware configuration which enables high frame rate capture of full 2D spatial and 1D spectral data. Compressive sensing techn ...

    STTR Phase I 2014 Department of DefenseArmy
  2. Printed, Flexible Ultracapacitors Based on Novel, High-Performance Carbon Nanomaterials (1000-262)

    SBC: SI2 TECHNOLOGIES, INC.            Topic: A13AT003

    SI2 Technologies, Inc. (SI2) proposes to develop printed, high-performance ultracapacitors to meet the Army"s need for lightweight energy storage. SI2 will leverage its demonstrated expertise in ink jet printing and our partner"s expertise with carbon nanoparticle synthesis to develop low-cost, flexible, printed ultracapacitors. SI2 has considerable experience in the roll-to-roll deposition of ...

    STTR Phase I 2014 Department of DefenseArmy
  3. Few-optical-cycle LWIR laser system

    SBC: Q-PEAK INCORPORATED            Topic: A14AT006

    Q-Peak, Inc. in collaboration with CREOL proposes to develop a novel concept of long-wave IR (LWIR) femtosecond laser system. Current laser systems suffer from complexity due to the use of multiple nonlinear stages to achieve the desired wavelength and have issues with power scaling. The proposed system will consist of 2.5 um femtosecond regenerative amplifier system pumping a single OPA stage bas ...

    STTR Phase I 2014 Department of DefenseArmy
  4. Pathogen Specific Antimicrobial Coatings for Fabrics

    SBC: Giner, Inc.            Topic: A14AT012

    Antimicrobial treatment of military textile systems is intended to provide enhanced protection to the Warfighter in the field by preventing colonization of harmful bacteria that cause problems such as odor, dermatitis, and skin irritation. Current treatments can impart antimicrobial functionality to textiles; however, they all possess broad-spectrum antimicrobial activity, affecting all skin bacte ...

    STTR Phase I 2014 Department of DefenseArmy
  5. Widely Tunable High Power Quantum Cascade Laser Arrays for Standoff Detection

    SBC: EOS Photonics            Topic: A14AT015

    To achieve the goals of this program improving spectral coverage and output power of monolithic QCL sources as well as the development of a production and manufacturing plan - we propose to develop in collaboration with MIT Lincoln Laboratory a broadly tunable high power source that is based on Eos"proprietary QCL array technology. The current generation of Eos"commercially available fully packag ...

    STTR Phase I 2014 Department of DefenseArmy
  6. Development of small near-infrared laser system capable of improving immune respo

    SBC: SEMINEX CORPORATION            Topic: NIAID

    DESCRIPTION (provided by applicant): The broad and long-term objective of this project is to amplify the effectiveness of vaccines without the use of chemical or biological adjuvants. We will address this objective by demonstrating the feasibility for small laser- based devices to enhance responses to intradermal vaccination. A number of investigators have shown that a promising new way to make va ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Therapeutic Utility of renalase and renalase peptides in cisplatin-mediated renal

    SBC: BESSOR PHARMA, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): Cisplatin is a cornerstone therapy for a number of cancers including testicular, bladder, ovarian and lung. It is also used to treat cancers in children. In all cases there is a high incidence of acute kidney injury (AKI) that can also lead to later stage kidney damage. This risk limits its use. We have found in pilot studies that renalase, or peptide fragment ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. DNP Polarization Agents for Real-Time Metabolic Imaging and Clinical Diagnosis

    SBC: DYNUPOL, INC.            Topic: NCI

    Project Summary / Abstract Although standard MRI techniques provide valuable structural insight, a related technique known as magnetic resonance spectroscopy (MRS) adds powerful real-time metabolic information about the tissues under study. MRS provides early detection of disease, monitoring treatment efficacy, and, in the case of cancer, a dramatic reduction in unnecessary biopsies. However, bro ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Developing Inhibitors of the STARS/SRF Pathway for Treatment of Type 2 Diabetes

    SBC: Jenesis Biosciences LLC            Topic: NIDDK

    DESCRIPTION (provided by applicant): Type 2 diabetes (T2D) has reached epidemic proportions in the United States, affecting an estimated 8.3% of the population. Unfortunately, the majority of individuals with diabetes continue to have suboptimal control ofglucose, therefore new and improved approaches to prevention and treatment are sorely needed. Dr. Mary Elizabeth Patti's laboratory at the ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Novel commensal polysaccharide treats multiple sclerosis through Treg modulation

    SBC: SYMBIOTIX BIOTHERAPIES, INC.            Topic: NIAID

    Abstract Multiple sclerosis (MS) is a chronic demyelinating inflammatory disease that is the most common neurological disease of young adults, affecting over 350,000 patients in the US and over 2.5 million patients worldwide. MS is a disease of high unmetmedical need, currently treatable with one of several approved drugs, all of which result in either immune modulation or significant immunosuppre ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government